Search

Search results

8 results found

HiRM RNA Technologies Showcase

Dr. Heng hosted Dr. Vikrant Kumar, Head of Bioinformatics at Mirxes, for a Harvard Institute of RNA Medicine (HiRM) RNA technologies showcase. Dr. Kumar's talk was about spatially resolved sub-cellular transcriptomics (Stereo-seq) and its applications. How advances in generating high resolution...

HiRM/MiRXES Workshop 2023

Dr. Heng presented a talk, "Using miRNA profiling technologies to assess breast cancer patient response to platinum-based chemotherapy" at the 2023 Harvard Institute for RNA Medicine / MiRXES workshop. https://www.linkedin.com/feed/update/urn:li:activity:7060326293812219904?utm_source=share&utm...

NCI CRCHD Grantee Video

Dr Heng was invited by NCI Center to Reduce Cancer Health Disparities (CRCHD) to share her story about the moment that inspired her to work in transgender cancer research. https://twitter.com/NCICRCHD/status/1665818273626353666?s=20

NCI DCB Breast Cancer Awareness Month

NCI Division of Cancer Biology (DCB) highlighted Dr. Heng's DCB-supported breast cancer research on Twitter/X for Breast Cancer Awareness in October. https://x.com/NCICancerBio/status/1717988909551071461?s=20

Harvard Medical School Pathology Retreat

Dr. Heng represented BIDMC Dept of Pathology at the Harvard-wide retreat, and presented her research titled, "Transgender breast cancer risk and treatment

HMS Program Diversity Award Nomination

Transgender Breast Care Working Group, led by Dr. Heng was nominated for the 2023 Group/Program Diversity Award given by Harvard Medical School. Although HMS is unable to honor each nominee with an award, HMS believes that being nominated is an honor unto itself and hope that the team will continue...

AACR Cancer Health Disparities Meeting

Dr. Heng's team will be presenting 3 abstracts at this upcoming AACR conference: Effect of testosterone therapy on quantitative breast lobular atrophy in transmasculine individuals (Short Talk) Effect of cross-sex testosterone therapy on Pik3ca-driven breast cancer incidence in mice (Poster) Effect...

USCAP annual meeting 2024

Congratulations to Dr Baker. Her abstract, "Increased Stem Cell Marker Expression in the Breast is Associated with Decreased Terminal Duct Lobular Unit Involution " has been accepted for Poster presentation at the USCAP annual meeting 2024.